AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in <i>Gars<sup>P278KY/+</sup></i> mice.

Ozes, Burcak; Moss, Kyle; Myers, Morgan; Ridgley, Alicia; Chen, Lei; Murrey, Darren; Sahenk, Zarife

AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in Gars^P278KY/+ mice.

Ozes, Burcak; Moss, Kyle; Myers, Morgan; Ridgley, Alicia; Chen, Lei; Murrey, Darren; Sahenk, Zarife.

Affiliation

Ozes B; Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Moss K; Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Myers M; Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Ridgley A; Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Chen L; Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Murrey D; Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
Sahenk Z; Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.

Brain Commun ; 3(4): fcab252, 2021.

Article in En | MEDLINE | ID: mdl-34755111

Key words

AAV; CMT2D; NT-3; gars

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Brain Commun Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google